Kidney Cancer Association Announces 2018 Young Investigator Award Winners

Cape Coral, FL, May 25, 2018 --(PR.com)-- The Kidney Cancer Association has announced the winners of its annual Young Investigator Award (YIA). The award provides funding to promising doctors to pursue careers in kidney cancer research. Since the award’s inception, the Kidney Cancer Association has funded dozens of projects projects, that in turn, have further improved the quality of life of those diagnosed with kidney cancer.

Each of the doctors was awarded $50,000 that will be received in two installments over 12 months to the awardee’s institution.

To qualify for the award, candidates must have attained a postgraduate degree or a doctoral degree and currently be in their subspecialty training at an academic medical institution at the time of grant submission and lastly, candidates must be planning an investigative career in kidney cancer.

The winners from this year include:

Danos Christodoulou, Ph.D., Harvard Medical School, whose area of focus includes transcriptomic approaches to identify cancer related metabolic pathways that assist with therapeutic manipulation.

Pavlos Msaouel, M.D., Ph.D., University of Texas MD Anderson Cancer Center, whose area of focus includes studying rare renal cell carcinomas.

Dr. Patrick G. Pilié, M.D., University of Texas MD Anderson Cancer Center, whose area of focus includes identifying and targeting DNA damage response deficiency in clear cell renal cell carcinoma.

Xiao Wei, M.D., M.A.S., Dana-Farber Cancer Institute, whose area of focus includes PD-L1 and VEGF coinhibition in advanced non-clear cell renal cell carcinoma.

For more information about the award, go to www.kidneycancer.org/research-grant-applications/.

About the Kidney Cancer Association:

The Kidney Cancer Association is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest kidney cancer charity, with members in more than 100 countries. We fund, promote and collaborate with the National Cancer Institute (NCI), American Society for Clinical Oncology (ASCO), American Urological Association (AUA) and other institutions on research projects. We educate families and physicians, and serve as an advocate on behalf of patients at the state and federal levels in the United States and globally.